Clinical Trials Logo

Clinical Trial Summary

To date, there is a lack of consensus concerning the optimal timing for removal of the urethral catheter, its related complications, the effectiveness in prophylactic drug use to reduce complication, and the patient reported outcomes (quality of life) after robot-assisted laparoscopic prostatectomy (RALP). The purpose of this study is to determine the impact of tamsulosin on voiding patterns following early urethral catheter removal after RALP for prostate cancer.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01209988
Study type Interventional
Source Asan Medical Center
Contact Choung-Soo Kim, M.D.
Phone 82-2-3010-3734
Email cskim@amc.seoul.kr
Status Recruiting
Phase N/A
Start date April 2010
Completion date December 2011